SG10201602309VA - Taxane and abeo-taxane analogs - Google Patents
Taxane and abeo-taxane analogsInfo
- Publication number
- SG10201602309VA SG10201602309VA SG10201602309VA SG10201602309VA SG10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA
- Authority
- SG
- Singapore
- Prior art keywords
- taxane
- abeo
- analogs
- taxane analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161472968P | 2011-04-07 | 2011-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201602309VA true SG10201602309VA (en) | 2016-05-30 |
Family
ID=48781786
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013074919A SG194128A1 (en) | 2011-04-07 | 2012-04-06 | Taxane and abeo-taxane analogs |
| SG10201602309VA SG10201602309VA (en) | 2011-04-07 | 2012-04-06 | Taxane and abeo-taxane analogs |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013074919A SG194128A1 (en) | 2011-04-07 | 2012-04-06 | Taxane and abeo-taxane analogs |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8912229B2 (en) |
| EP (1) | EP2694055A4 (en) |
| JP (1) | JP5970536B2 (en) |
| KR (1) | KR20140048113A (en) |
| CN (1) | CN103764138A (en) |
| AU (1) | AU2012364858A1 (en) |
| CA (1) | CA2832596A1 (en) |
| MX (1) | MX2013011694A (en) |
| SG (2) | SG194128A1 (en) |
| WO (1) | WO2013106029A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103763928B (en) * | 2011-06-06 | 2016-09-21 | 阿伯疗法责任有限公司 | The lipophilic prodrugs of the acid instability of cancer chemotherapeutic agent |
| CN104650109B (en) * | 2013-11-22 | 2019-01-01 | 江苏天士力帝益药业有限公司 | Bearing taxanes |
| JP2023549921A (en) | 2020-11-19 | 2023-11-29 | スペクシス アーゲー | Pharmaceutical combinations comprising peptide CXCR4 inhibitors and taxanes for treating cancer |
| EP4000613A1 (en) | 2020-11-19 | 2022-05-25 | Polyphor Ag | Pharmaceutical combinations comprising a peptide cxcr4 inhibitor and a taxane for treating cancer |
| EP4223292A1 (en) | 2022-02-07 | 2023-08-09 | Cellestia Biotech AG | Pharmaceutical combinations for treating cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993021173A1 (en) * | 1992-04-17 | 1993-10-28 | Abbott Laboratories | Taxol derivatives |
| CN1886400A (en) * | 2003-09-25 | 2006-12-27 | 泰普斯特医药公司 | 9, 10-alpha, alpha-OH-taxane analogs and methods for production thereof |
| WO2008106621A1 (en) * | 2007-02-28 | 2008-09-04 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| WO2008121476A1 (en) * | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| US20080207743A1 (en) * | 2007-02-28 | 2008-08-28 | Rodger Lamb | Biologically Active Taxane Analogs and Methods of Treatment |
| WO2011028571A1 (en) * | 2009-09-01 | 2011-03-10 | Tapestry Pharmaceuticals, Inc. | Taxane analogues, their use, pharmaceutical compositions containing them, and processes for their preparation |
-
2012
- 2012-04-06 MX MX2013011694A patent/MX2013011694A/en unknown
- 2012-04-06 JP JP2014504036A patent/JP5970536B2/en not_active Expired - Fee Related
- 2012-04-06 SG SG2013074919A patent/SG194128A1/en unknown
- 2012-04-06 CA CA2832596A patent/CA2832596A1/en not_active Abandoned
- 2012-04-06 EP EP12864819.3A patent/EP2694055A4/en not_active Withdrawn
- 2012-04-06 US US14/110,423 patent/US8912229B2/en not_active Expired - Fee Related
- 2012-04-06 CN CN201280027957.4A patent/CN103764138A/en active Pending
- 2012-04-06 KR KR1020137029373A patent/KR20140048113A/en not_active Application Discontinuation
- 2012-04-06 AU AU2012364858A patent/AU2012364858A1/en not_active Abandoned
- 2012-04-06 WO PCT/US2012/032568 patent/WO2013106029A1/en active Application Filing
- 2012-04-06 SG SG10201602309VA patent/SG10201602309VA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140093503A1 (en) | 2014-04-03 |
| CN103764138A (en) | 2014-04-30 |
| EP2694055A4 (en) | 2014-09-10 |
| WO2013106029A1 (en) | 2013-07-18 |
| CA2832596A1 (en) | 2013-07-18 |
| JP2014512362A (en) | 2014-05-22 |
| AU2012364858A1 (en) | 2013-11-21 |
| KR20140048113A (en) | 2014-04-23 |
| NZ617430A (en) | 2016-05-27 |
| SG194128A1 (en) | 2013-11-29 |
| JP5970536B2 (en) | 2016-08-17 |
| MX2013011694A (en) | 2014-05-27 |
| EP2694055A1 (en) | 2014-02-12 |
| US8912229B2 (en) | 2014-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100012I1 (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| ZA201401603B (en) | Novel clucagon analogues | |
| PL3075273T3 (en) | Inhalator component | |
| EP2692380A4 (en) | Syringe | |
| PL3701800T3 (en) | Use | |
| EP2719413A4 (en) | Tri-ring syringe | |
| AU338419S (en) | Dumbell | |
| IL229243B (en) | Complement factor b analogs and their uses | |
| EP2774642A4 (en) | Syringe | |
| SG10201602309VA (en) | Taxane and abeo-taxane analogs | |
| GB201404963D0 (en) | Game entry | |
| PL2729222T3 (en) | Shuttlecock | |
| GB201118334D0 (en) | Novel dosage form | |
| EP2687212A4 (en) | Medicament | |
| GB2490723B (en) | Modified syringe | |
| GB201118802D0 (en) | Game | |
| ME03310B (en) | 4 - imidazopyridazin- 1-yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors | |
| GB201115238D0 (en) | Pit-stop easy | |
| GB201216534D0 (en) | Games | |
| GB201121138D0 (en) | Placement game | |
| GB201102529D0 (en) | Fine B-Day | |
| GB201119436D0 (en) | Use | |
| GB201109368D0 (en) | Eyeliner effect | |
| GB201107384D0 (en) | Jewelled wellys | |
| GB201108226D0 (en) | Peg |